Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies (Q90451569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

review article

1 reference

title

Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

Dawit Zewdu Wondafrash

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Ebrahim M Yimer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Kaleab Alemayehu Zewdie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Tsion Zewdu Desalegn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Arega Gashaw Tsige

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Betelhem Anteneh Adamu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

Journal of Diabetes Research

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

5214751

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

14 April 2020

copyright license

start time

28 February 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Pooling of animal experimental data reveals influence of study design and publication bias

1 reference

12 December 2020

Effect of atorvastatin and hydroxychloroquine combination on blood glucose in alloxan-induced diabetic rats

1 reference

12 December 2020

Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases

1 reference

12 December 2020

Controversies in the cardiovascular management of type 2 diabetes

1 reference

12 December 2020

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

12 December 2020

Humphrey visual field findings in hydroxychloroquine toxicity

1 reference

12 December 2020

Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals

1 reference

12 December 2020

Chloroquine stimulates glucose uptake and glycogen synthase in muscle cells through activation of Akt.

1 reference

12 December 2020

Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial

1 reference

12 December 2020

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone.

1 reference

12 December 2020

Sodium glucose co-transporter 2 (SGLT2) inhibitors: new among antidiabetic drugs

1 reference

12 December 2020

A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role

1 reference

12 December 2020

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study

1 reference

12 December 2020

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

1 reference

12 December 2020

Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial

1 reference

12 December 2020

Hydroxychloroquine-related retinal toxicity

1 reference

12 December 2020

Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines

1 reference

12 December 2020

Hydroxychloroquine, a promising choice for coronary artery disease?

1 reference

12 December 2020

The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition

1 reference

12 December 2020

Rheumatoid arthritis, insulin resistance, and diabetes

1 reference

12 December 2020

Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis

1 reference

12 December 2020

PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

1 reference

12 December 2020

Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients

1 reference

12 December 2020

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.

1 reference

12 December 2020

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

1 reference

12 December 2020

Hydroxychloroquine: An old drug with new relevance

1 reference

12 December 2020

Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated Complications

1 reference

12 December 2020

Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors

1 reference

12 December 2020

Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review

1 reference

12 December 2020

The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure

1 reference

12 December 2020

Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1155/2020/5214751

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32190699%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

PubMed publication ID

32190699

1 reference